JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 1990; 15:231-237
© 1990 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhu, B.
Right arrow Articles by Parmley, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhu, B.
Right arrow Articles by Parmley, W.

Regression of atherosclerosis in cholesterol-fed rabbits: effects of fish oil and verapamil

BQ Zhu, RE Sievers, WM Isenberg, DL Smith, and WW Parmley

Department of Medicine, University of California, San Francisco.

Previous studies have shown that either fish oil or verapamil can attenuate the development of atherosclerosis in the lipid-fed rabbit. The present study was designed to evaluate the individual and combined effects of these two interventions on regression. Seventy New Zealand rabbits in seven groups (10 each) were fed a 0.3% cholesterol diet for 10 weeks. Control group C10 was then killed. Control group C20 was fed a 0.3% cholesterol diet and the other five groups were fed a normal diet for an additional 10 weeks. Group F in three treated groups received 2 ml/day of fish oil (Proto-Chol, eicosapentaenoic acid, 180 mg/ml and docosahexaenoic acid, 120 mg/ml) by gavage. Group V received verapamil, 2 g/1,000 ml drinking water, and group FV received both fish oil and verapamil for an additional 10 weeks. Group CF (control for fish oil) received 2 ml/day of water by gavage and group CV (control for verapamil) received water without gavage for an additional 10 weeks. The percent of aortic and pulmonary atherosclerosis was measured by planimetry of sudanophilic lesions. The percent of aortic lesions in the four control groups (C20, C10, CF and CV) was 57 +/- 22, 40 +/- 15, 40 +/- 14 and 33 +/- 25%, respectively. The fish oil or verapamil groups (F, V, FV) showed a significant reduction in aortic lesions: 15 +/- 17%, p less than 0.05; 16 +/- 12%, p less than 0.05; and 26 +/- 24%, p = NS, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Y. Stein and O. Stein
Does Therapeutic Intervention Achieve Slowing of Progression or Bona Fide Regression of Atherosclerotic Lesions?
Arterioscler. Thromb. Vasc. Biol., February 1, 2001; 21(2): 183 - 188.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. C. Schwenke
Comparison of Aorta and Pulmonary Artery : I. Early Cholesterol Accumulation and Relative Susceptibility to Atheromatous Lesions
Circ. Res., September 19, 1997; 81(3): 338 - 345.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
D. C. Schwenke
Comparison of Aorta and Pulmonary Artery : II. LDL Transport and Metabolism Correlate With Susceptibility to Atherosclerosis
Circ. Res., September 19, 1997; 81(3): 346 - 354.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. L. Barbeau, K. F. Klemp, J. R. Guyton, and K. A. Rogers
Dietary Fish Oil : Influence on Lesion Regression in the Porcine Model of Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., April 1, 1997; 17(4): 688 - 694.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. C. Candipan, B.-y. Wang, R. Buitrago, P. S. Tsao, and J. P. Cooke
Regression or Progression : Dependency on Vascular Nitric Oxide
Arterioscler. Thromb. Vasc. Biol., January 1, 1996; 16(1): 44 - 50.
[Abstract] [Full Text]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1990 by the American College of Cardiology Foundation.